Cystitis Clinical Trials

67 recruitingLast updated: May 13, 2026

There are 67 actively recruiting cystitis clinical trials across 27 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 1, Phase 4, Early Phase 1. Top locations include Moscow, Russia, Winston-Salem, North Carolina, United States, Hangzhou, Zhejiang, China. Updated daily from ClinicalTrials.gov.


Cystitis Trials at a Glance

67 actively recruiting trials for cystitis are listed on ClinicalTrialsFinder across 6 cities in 27 countries. The largest study group is Not Applicable with 26 trials, with the heaviest enrollment activity in Moscow, Winston-Salem, and Hangzhou. Lead sponsors running cystitis studies include Boston Children's Hospital, Fondazione IRCCS Policlinico San Matteo di Pavia, and JSC NextGen.

Treatments under study

About Cystitis Clinical Trials

Looking for clinical trials for Cystitis? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Cystitis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Cystitis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 67 trials

Recruiting
Not Applicable

Investigation of PEMF Therapy for Female Patients With IC/BPS

Interstitial CystitisBladder Pain SyndromeChronic Interstitial Cystitis
Wake Forest University Health Sciences75 enrolled1 locationNCT05149573
Recruiting
Phase 1

Daily Nitrofurantoin Versus Bladder Fulguration Plus Daily Nitrofurantoin for Women With Recurrent Urinary Tract Infections

Recurrent UTIsCystitis, Recurrent
University of Texas Southwestern Medical Center104 enrolled2 locationsNCT06907199
Recruiting
Not Applicable

USG-Guided TAPA vs RIFB Block for Postoperative Analgesia in Laparoscopic Cholecystectomy

Postoperative nausea and vomitingPostoperative PainCholelithiasis+1 more
Hitit University70 enrolled1 locationNCT07552701
Recruiting

Diagnostic Value of Deep Learning-Based Rapid MRI in Preoperative Evaluation of Acute Cholecystitis

Acute Cholecystitis
Peking Union Medical College Hospital300 enrolled1 locationNCT07551375
Recruiting
Not Applicable

GALLVIA Trial: EUS-Guided vs Transpapillary Gallbladder Drainage for Acute Calculous Cholecystitis

Acute Calculous Cholecystitis
Aichi Medical University90 enrolled5 locationsNCT07536191
Recruiting

Prospective Registry Of Therapeutic EndoscopiC ulTrasound

Chronic PancreatitisGastric Outlet ObstructionAcute Pancreatic Fluid Collection+3 more
Paolo Giorgio Arcidiacono, MD510 enrolled1 locationNCT04813055
Recruiting
Phase 3

EUS-GBD vs Antibiotics for Patients at High Risk for Cholecystectomy

Acute Cholecystitis
Chinese University of Hong Kong110 enrolled1 locationNCT05893511
Recruiting
Not Applicable

Early vs Delayed Intravesical Blad-Care During BCG Therapy

Urinary Bladder NeoplasmsBCG-Induced Cystitis
BLAD-HYA Group56 enrolled1 locationNCT07495072
Recruiting

Study of the Effects of Anticoagulant Interruption Covered by Percutaneous Left Atrial Occlusion in Patients With Chronic Atrial Fibrillation and Radiation Cystitis at Risk of Bleeding

Non Valvular Atrial FibrillationRadiation Cystitis
University Hospital, Clermont-Ferrand40 enrolled1 locationNCT04701749
Recruiting

Feasibility Study of Non-Contact Imaging-Based Physiological Monitoring in the Operating Room

Liver NeoplasmsInguinal HerniaCholecystitis+1 more
Taipei Veterans General Hospital, Taiwan315 enrolled1 locationNCT07473687
Recruiting
Not Applicable

Moxibustion for the Prevention of Hemorrhagic Cystitis After Allo-HSCT

PreventionHematopoietic Stem Cell TransplantationHemorrhagic Cystitis+1 more
Yi Zhang266 enrolled4 locationsNCT06198517
Recruiting
Phase 2Phase 3

The Study is Being Conducted to Find a New Treatment for Patients Suffering From Interstitial Cystitis With Hunner's Lesions

Bladder Pain SyndromeICHunner Type Interstitial Cystitis
JSC NextGen180 enrolled1 locationNCT07459790
Recruiting
Phase 2Phase 3

The Study is Being Conducted to Find a New Treatment for Patients Suffering From Interstitial Cystitis Without Hunner's Lesions.

ICInterstitial Cystitis and Bladder Pain SyndromeInterstitial Cystitis, Chronic
JSC NextGen180 enrolled1 locationNCT07391306
Recruiting
Not Applicable

EPPIC: Easing Pelvic Pain Interventions Clinical Research Program

Chronic PainChronic Pelvic Pain SyndromeChronic Prostatitis+4 more
State University of New York at Buffalo240 enrolled3 locationsNCT05127616
Recruiting
Phase 2

Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)

Interstitial CystitisBladder Pain Syndrome
Vaneltix Pharma, Inc.50 enrolled5 locationsNCT06394830
Recruiting
Phase 2

Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS

Interstitial CystitisBladder Pain Syndrome
Vaneltix Pharma, Inc.120 enrolled14 locationsNCT05737121
Recruiting

Chronic Radiation Cystitis and Effect of Hyperbaric Oxygen Therapy on Patient Reported Outcomes and Urine Inflammatory Biomarkers

Radiation CystitisUrinary Tract Infection (Diagnosis)
Rachel A. Moses100 enrolled1 locationNCT07368647
Recruiting
Not Applicable

Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment

Chronic ProstatitisInterstitial CystitisBladder Pain Syndrome+8 more
Vanderbilt University Medical Center220 enrolled1 locationNCT06299683
Recruiting
Not Applicable

Acupuncture First for IC/BPS

Interstitial CystitisBladder Pain Syndrome
University Hospitals Cleveland Medical Center34 enrolled1 locationNCT06366269
Recruiting
Not Applicable

One vs. Two Stents for Gallbladder Disease

Biliary colicCholecystitisRecurrent Cholecystitis+1 more
Mayo Clinic30 enrolled1 locationNCT07222527